PTX 0.00% 4.0¢ prescient therapeutics limited

Pitt St Research Report..., page-11

  1. 5,844 Posts.
    lightbulb Created with Sketch. 17194
    I believe that the preference has always been to use Cell-Pryme A as a neoadjuvant.

    According to the patent, Cell-Pryme A should be administered at least 18 hours prior to CAR-T, dendritic cells or NK cells being administered.

    https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2022241515&_cid=P11-LP80EH-30307-1
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.000(0.00%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.1¢ 4.0¢ $3.084K 76.05K

Buyers (Bids)

No. Vol. Price($)
3 261637 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 679528 4
View Market Depth
Last trade - 10.53am 21/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.